x
d
s
k
b
i
o
p
h
a
r
m
a
Peptidomimetics
Peptidomimetics
Next-Gen Peptide Therapeutics
DSK Biopharma designs peptidomimetics with enhanced metabolic stability and receptor affinity.
Key Highlights:
- Incorporation of non-natural amino acids
- Backbone modification and cyclic peptide synthesis
- Structure–activity optimization for drug-like properties
We help clients overcome traditional peptide limitations by developing stable, bioavailable peptidomimetics tailored to their therapeutic targets.